TrialTherapeutic advances in respiratory disease

The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease.

Nawar Diar Bakerly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.